Ownership history in BARCLAYS PLC · 30 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in ADVERUM BIOTECHNOLOGIES INC (ADVM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 21 | -29,489 | -99.9% | 0.00% | $96 | — |
| 2025 Q1 | REDUCED | 29,510 | -10,377 | -26.0% | 0.00% | $129K | — |
| 2024 Q4 | ADDED | 39,887 | +4,055 | +11.3% | 0.00% | $186K | — |
| 2024 Q3 | ADDED | 35,832 | +19,965 | +125.8% | 0.00% | $252K | — |
| 2024 Q2 | REDUCED | 15,867 | -37,391 | -70.2% | 0.00% | $109K | — |
| 2024 Q1 | ADDED | 53,258 | +39,154 | +277.6% | 0.00% | $754K | — |
| 2022 Q1 | REDUCED | 14,104 | -91,344 | -86.6% | 0.00% | $18K | — |
| 2021 Q4 | ADDED | 105,448 | +56,142 | +113.9% | 0.00% | $185K | — |
| 2021 Q3 | REDUCED | 49,306 | -9,681 | -16.4% | 0.00% | $107K | — |
| 2021 Q2 | REDUCED | 58,987 | -120,259 | -67.1% | 0.00% | $207K | — |
As of 2025 Q3 — sorted by position size